semaglutide court ruling A South African has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company nutrient support Flavor:Variety pack With the growing use

semaglutide court ruling A South African has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company nutrient support Flavor:Variety pack With the growing use

With the growing use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro, new oral health concerns are emerging. Some patients report increased tooth sensitivity, enamel erosion, gum inflammation, and cavities — often

GLP-1 medications compared: Benefits and differences Gecko Studio // Shutterstock GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss

nutrient support

Flavor:Variety pack

[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Bomba M., Ciavardelli D., Silvestri E., Canzoniero L.M., Lattanzio R., Chiappini P., Piantelli M., Di Ilio C., Consoli A., Sensi S.L